BioCardia, Inc.
(NASDAQ : BCDA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.38%332.330.0%$4435.97m
BNTXBioNTech SE 1.78%267.520.0%$736.06m
NVAXNovavax, Inc. -15.80%135.1979.4%$598.76m
AMGNAmgen, Inc. 1.61%210.101.4%$555.09m
SNSSSunesis Pharmaceuticals, Inc. 3.75%6.370.7%$445.29m
REGNRegeneron Pharmaceuticals, Inc. 1.55%560.672.7%$438.27m
GILDGilead Sciences, Inc. 0.29%67.101.0%$414.29m
CCXIChemoCentryx, Inc. 3.00%34.662.9%$396.91m
ILMNIllumina, Inc. -0.20%413.243.3%$373.86m
XLRNAcceleron Pharma, Inc. -0.48%172.905.3%$348.63m
VRTXVertex Pharmaceuticals, Inc. 0.36%186.081.9%$270.73m
BIIBBiogen, Inc. -0.57%266.601.7%$242.14m
OCGNOcugen, Inc. 4.32%8.690.0%$184.04m
XENEXenon Pharmaceuticals, Inc. 2.11%30.440.4%$163.76m
CRSPCRISPR Therapeutics AG -1.75%98.510.6%$159.29m

Company Profile

BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.